| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.83B | -7.0% |
| R&D Expense | $91.0M | -17.3% |
| SG&A Expense | $2.43B | -18.8% |
| Operating Income | -$304.1M | -9.4% |
| Pre-tax Income | -$75.6M | +96.1% |
| Income Tax | $48.9M | +116.5% |
| Net Income | -$124.5M | +92.7% |
| EPS (Basic) | -$0.44 | +93.0% |
| EPS (Diluted) | -$0.44 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.31B | +136.4% |
| Short-term Investments | $1.24B | +99.3% |
| Accounts Receivable | $1.20B | +6.8% |
| Inventory | $455.2M | -31.6% |
| Current Assets | $8.10B | +65.5% |
| Total Assets | $60.94B | +6.7% |
| Current Liabilities | $5.83B | -27.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.25B | -48.5% |
| Capital Expenditures | $1.54B | -50.2% |
| Investing Cash Flow | -$3.05B | -8.5% |
| Financing Cash Flow | $4.48B | +1717.9% |
| Free Cash Flow | -$292.2M | +56.3% |
| +93.0% |
| Long-term Debt |
| $25.66B |
| +30.1% |
| Total Liabilities | $40.69B | +10.8% |
| Stockholders' Equity | $20.19B | +1.6% |